ANGO

AngioDynamics, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$15m31-Aug-2610-Q filed 08-Oct-26
Remaining authorization$031-Aug-2610-Q filed 08-Oct-26
Program expiryn/a—
Repurchased last quarterNot found in filings—
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
16-Jul-24$15m$0n/aOn July 16, 2024, the Board of Directors approved a share repurchase program (the "Repurchase Program") under which they authorized the Company the option to repurchase up to $ 15.0 million of its outstanding common stock.10-Q filed 08-Oct-26

Open-market repurchases

None reported in the filings we hold.

Filings through 31-Aug-26· checked 18-Nov-26